Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$226,826,040
-$21,179,627 QoQ
Shares Held
810,093
-18.1% QoQ
Ownership
0.999%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#21
of 1,040 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NORGES BANK holds $8,210,210,448 across 22 Diagnostics & Research names. LH ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,087,903 | $2,550,871,048 | |
| 2 | DHR |
Danaher Corp /De/
|
9,537,906 | $1,816,780,334 | |
| 3 | A |
Agilent Technologies, Inc.
|
3,869,544 | $513,991,529 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
399,539 | $510,415,067 | |
| 5 | NTRA |
Natera, Inc.
|
1,828,122 | $496,243,716 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
2,264,944 | $437,632,479 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,406,620 | $298,133,109 | |
| 8 | GH |
Guardant Health, Inc.
|
1,548,518 | $232,324,155 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,826,040 | 810,093 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $248,005,667 | 988,543 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $263,070,196 | 1,002,134 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $228,775,972 | 982,968 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $239,811,160 | 1,045,749 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $232,490,713 | 1,040,320 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $209,673,503 | 1,030,286 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||